Novo Nordisk takes on Pfizer in bid for obesity biotech Metsera | REUTERS #Reuters



Novo Nordisk takes on Pfizer in bid for obesity biotech Metsera | REUTERS
Denmark’s Novo Nordisk launched a rival bid for US obesity biotech firm Metsera, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative weight-loss drug market.

#News #Reuters #Newsfeed #novonordisk #pfizer #metsera #weightlossdrugs

Read the story here: https://reut.rs/47C2RHf

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://ift.tt/4gGIswf
Follow Reuters on Facebook: https://ift.tt/rv8JACl
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://ift.tt/94b3pXJ

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”

コメントを送信